HealthPolicy – Delhi Moves to Mandate Reporting of Leprosy Cases

HealthPolicy –  The Delhi government is considering a proposal to classify leprosy as a notifiable disease under the existing Epidemic Diseases framework, a step that could significantly strengthen disease monitoring and response in the capital.

The recommendation, currently awaiting approval, aims to align Delhi with several other Indian states where mandatory reporting of leprosy cases is already in place. If cleared, it will introduce a structured system requiring all healthcare providers to report confirmed cases to designated health authorities.

Mandatory Reporting Framework Under Consideration

Under the proposed system, every diagnosed case of leprosy would need to be reported to the District Leprosy Officer. This requirement would apply uniformly to government hospitals, private clinics, and independent practitioners.

Health officials say detailed protocols will be issued to ensure clarity and compliance across the healthcare sector. The reporting mechanism is expected to create a centralized database, enabling authorities to track the spread of the disease more effectively.

Focus on Early Detection and Timely Treatment

A key objective behind the proposal is to identify cases at an earlier stage. Early diagnosis is critical in preventing complications and limiting transmission. Officials believe that mandatory reporting will help bridge existing gaps in detection.

Patients diagnosed with leprosy are treated using Multi-Drug Therapy, a globally recommended regimen that is already provided free of charge at government healthcare facilities. Strengthening reporting systems could ensure that more patients receive timely access to this treatment.

Persistent Challenge Despite Official Elimination

India declared the elimination of leprosy as a public health concern in 2005, based on achieving a defined threshold of prevalence. However, the disease has not been completely eradicated. The country continues to contribute a significant share of new cases reported globally each year.

Public health data suggests that India accounts for nearly 59 percent of annual new leprosy cases worldwide. This indicates that while progress has been made, challenges remain in fully controlling the disease.

Underreporting in Private Healthcare Sector

One of the major concerns highlighted by recent research is the role of underreporting, particularly within the private healthcare system. A nationwide study found that approximately 44.1 percent of leprosy patients seek treatment in private facilities, where cases are often not reported to the National Leprosy Eradication Programme.

This gap in reporting creates what experts describe as “hidden clusters” of infection. Without accurate data, it becomes difficult for authorities to assess the true scale of the disease and implement targeted interventions.

Experts Support Move for Better Surveillance

Public health specialists have largely welcomed the proposal, noting that making leprosy a notifiable disease could improve transparency and accountability in case reporting. Accurate data collection is essential for designing effective control strategies and monitoring treatment outcomes.

Experts also emphasize that consistent reporting can help standardize treatment practices across different healthcare providers. This is particularly important in preventing the misuse of medication, which could lead to drug resistance.

Potential Impact on Public Awareness and Stigma

Beyond surveillance, the move is also expected to contribute to reducing the social stigma associated with leprosy. Increased awareness and official recognition of the disease within public health systems may encourage more individuals to seek treatment without fear of discrimination.

Health authorities believe that a comprehensive approach—combining early detection, mandatory reporting, and accessible treatment—can play a crucial role in further reducing the burden of leprosy in the region.